Developer plots sprawling biotech complex near Boston

A developer has blueprinted a sprawling 250-acre biotech complex in the Boston area's thriving life sciences cluster. Patriot Partners says it will negotiate with the town of Burlington for the land and development costs have been estimated in the hundreds of millions of dollars.

The developers do not have any tenants lined up for the laboratory and office space they're planning to build, but the suburbs around Boston have been attracting a large number of developers from Cambridge and other sites. It's also the first big development announced since the Legislature approved a $1 billion program to support the industry.

- reaad the story from the Boston Globe

Suggested Articles

The patient was hospitalized with febrile neutropenia in the weeks after receiving the drug and died 52 days post-treatment with the CAR-T therapy.

The trial has been paused since early September while FDA reviews the safety of the vaccine in light of a reported case of an inflammatory disorder.

Biogen is cutting its experimental multiple sclerosis drug opicinumab as well as an spinal muscular atrophy candidate amid a third-quarter clear-out.